ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Orexigen Therapeutics, Inc. 

48 Wall Street
Suite 1100
New York  New York  10005  U.S.A.
Phone: 212-918-4650 Fax: 212-918-4801


SEARCH JOBS


Industry
Biotechnology






 Company News
Top Cardiologist Says Diet Drug Maker Orexigen (OREX) Misled Patients And Investors 5/13/2015 6:40:32 AM
Takeda (TKPYY) Threatens to End Orexigen (OREX) Partnership Over Stopped Obesity Study 5/13/2015 6:36:31 AM
Orexigen (OREX) Provides Statement On Termination Of The Light Study And Updates On Contrave Collaboration With Takeda Pharmaceuticals 5/13/2015 6:31:50 AM
Orexigen (OREX) Aborts Required Study For Diet Drug Contrave 5/12/2015 6:58:18 AM
Orexigen (OREX) To Speak At The Bank of America (BAC) Merrill Lynch Health Care Conference 5/11/2015 7:57:53 AM
Orexigen (OREX) Reports Financial And Business Results For The First Quarter Ended March 31, 2015 5/8/2015 11:13:37 AM
Orexigen (OREX) To Host First Quarter 2015 Financial Results Conference Call 5/5/2015 6:56:07 AM
Orexigen (OREX) Announces Receipt Of Paragraph IV Certification Notice 4/23/2015 12:40:16 PM
Orexigen (OREX) To Speak At The Needham Healthcare Conference 4/13/2015 7:06:10 AM
Orexigen (OREX) Announces That Tom Cannell Has Joined As Chief Commercial Officer 3/30/2015 9:00:47 AM
12345678910...